Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys.
A gel consisting of agarose and oxyhemoglobin (OxyHb) was developed so that, when placed in the subarachnoid space, OxyHb would be slowly released, simulating lysis of erythocytes after subarachnoid hemorrhage. The system was used to investigate the importance of reactions mediated by free radicals in the genesis of OxyHb-induced vasospasm in monkeys. Seventeen monkeys were randomly assigned to have subarachnoid placement, on Day 0, of one of the following: 1) agarose gel alone (n = 2); 2) agarose plus OxyHb (n = 3); 3) agarose plus OxyHb plus intrathecal administration of superoxide dismutase and catalase (n = 6); and 4) agarose plus OxyHb plus intrathecal administration of placebo (n = 6). Vasospasm was assessed by comparison of angiograms performed on Day 0 and 7 days after subarachnoid placement of compounds, and by electron microscopy. OxyHb alone caused significant reduction in the diameter of the middle cerebral artery (40 +/- 8%, P less than 0.005, paired t test), which was associated with ultrastructural damage to smooth muscle. Treatment with superoxide dismutase plus catalase or with placebo attenuated vasospasm of the middle cerebral artery, although significant narrowing persisted in both groups (27 +/- 12% and 26 +/- 13%, respectively, P less than 0.05, paired t test). Analysis of variance showed no difference in the degree of vasospasm between groups exposed to subarachnoid placement of OxyHb. Cerebrospinal fluid aspirated from the cisterna magna on Day 7 contained elevated activity of superoxide dismutase in animals that received treatment. Malondialdehyde was undetectable in cerebrospinal fluid after subarachnoid placement of agarose alone, although it was present in similar amounts in all groups that received subarachnoid placement of OxyHb. Since intrathecal superoxide dismutase and catalase failed to protect against OxyHb-induced vasospasm, mechanisms mediated by free radicals may not be important in its genesis. As only one combination of doses of superoxide dismutase and catalase was administered, however, it may be that other dosage schedules might be efficacious.
Macdonald
R L
RL
Department of Surgery, University of Alberta, Edmonton, Canada.
Weir
B K
BK
Runzer
T D
TD
Grace
M G
MG
Poznansky
M J
MJ
D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D002374:Catalase / Q000008:administration & dosage / Q000627:therapeutic use*; D002533:Cerebral Angiography; D003692:Delayed-Action Preparations; D004195:Disease Models, Animal; D016166:Free Radical Scavengers; D005609:Free Radicals; D005782:Gels; D006461:Hemolysis; D007278:Injections, Spinal; D002546:Ischemic Attack, Transient / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008252:Macaca fascicularis; D008297:Male; D008315:Malondialdehyde / Q000134:cerebrospinal fluid; D010108:Oxyhemoglobins / Q000008:administration & dosage / Q000633:toxicity*; D011897:Random Allocation; D012685:Sepharose; D013345:Subarachnoid Hemorrhage; D013346:Subarachnoid Space; D013482:Superoxide Dismutase / Q000008:administration & dosage / Q000627:therapeutic use*
D000975:Antioxidants; D003692:Delayed-Action Preparations; D016166:Free Radical Scavengers; D005609:Free Radicals; D005782:Gels; D010108:Oxyhemoglobins; D008315:Malondialdehyde; D012685:Sepharose; D002374:Catalase; D013482:Superoxide Dismutase